CinDome Pharma Announces $40 Million Series B Extension
CinDome Pharma Announces $40 Million Series B Extension
CinDome Pharma announces successful completion of thorough QT study of CIN- 102
CinDome Pharma announced the negative results of a clinical thorough QT/QTc study of CIN-102.
CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)
CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102).
